Biopsychosocial (BETY) exercise program for children and adults with scleroderma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional trial will deliver the Cognitive Exercise Therapy Approach (BETY), a biopsychosocial exercise program, to children (7–18) and adults with scleroderma and compare outcomes with a control group. BETY combines physical exercises, cognitive-behavioral techniques, and group support to promote pain management, functional gains, and behavioral change. Key exclusions include advanced heart, lung, liver, or kidney disease, neurological disease, malignancy, developmental delay, and recent participation in a regular exercise program; outcomes will include measures of function, muscle strength, vascular and inflammatory markers, and psychosocial status. The intervention has been used previously via telerehabilitation in systemic sclerosis and is being tested at Hacettepe University to see if similar benefits extend across pediatric and adult scleroderma patients.

Why it matters

Who can join: the full rules

\*For a child diagnosed with scleroderma\*

Inclusion Criteria:

* Cases diagnosed with scleroderma,
* Cases aged 7-18 years will be included.

Exclusion Criteria:

* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Cases that are not willing to participate in the study will be excluded.
* History of developmental delay
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study

\*For adults diagnosed with scleroderma\*

Inclusion Criteria:

* Individuals diagnosed with scleroderma,
* Individuals over the age of 18 will be included.

Exclusion Criteria:

* Advanced heart/lung/liver/kidney disease, neurological disease, and malignancies
* Individuals who are not willing to participate in the study will be excluded.
* Having participated in a regular exercise program for the past 3 months
* Individuals who are not willing to participate in the study

Where it's running

• Hacettepe University
  Ankara, Altındağ, Turkey (Türkiye) Recruiting

Study contacts

• Study coordinator: Orkun Tüfekçi, PT, PhD (c)
• Email: orkuntf@gmail.com
• Phone: +903123052525

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Physical performance and daily function in people with scleroderma

  This project will test which questionnaires and simple physical tests best measure physical performance and daily functioning in children and adults with scleroderma.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07183072

• Chewing and swallowing performance in people with scleroderma

  This project will see how children and adults with scleroderma chew and swallow and collect biopsychosocial information using questionnaires.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07182981

• First-in-human test of PRO-203 in healthy adults and people with systemic sclerosis

  Researchers will test a single subcutaneous dose of PRO-203 in healthy adults and in people with systemic sclerosis to see if it is safe and how the body handles it.

  Recruiting at 12 sites Phase 1/2 Prolium Bioscience, Inc · Melbourne, Victoria and 12 other locations · NCT07641634

• Turkish PASTUL questionnaire for measuring upper‑limb skin thickness in systemic sclerosis

  This project will test a Turkish version of the PASTUL questionnaire to see if people with systemic sclerosis can use it to measure their upper‑limb skin thickness.

  Recruiting Hacettepe University · Çankaya, Ankara · NCT07182968

• AlloNK® therapy combined with rituximab for treating certain autoimmune diseases

  This study is testing if a new treatment called AlloNK® combined with rituximab can help people with tough-to-treat autoimmune diseases feel better.

  Recruiting at 52 sites Phase 2 Artiva Biotherapeutics, Inc. · Tuscaloosa, Alabama and 51 other locations · NCT06991114

• Progressive Muscle Relaxation for Fatigue and Breathing in Systemic Sclerosis

  Aims to see if progressive muscle relaxation can help reduce fatigue and breathing difficulties and improve lung function in adults with systemic sclerosis.

  Recruiting University of Gaziantep · Gaziantep, Şehitkamil · NCT07842133

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.